Anti-cancer drug price cuts take effect Nov 9, offer ₹3,500-cr relief

Revised maximum retail prices for 137 anti-cancer medicines take effect November 9, offering ₹3,502 crore in estimated annual consumer savings. NPPA capped trade margins on 1,225 formulations from 76 manufacturers; 600 brands see cuts exceeding 50%, with the steepest reduction at 96.45%. Retailers and hospitals must display revised price lists publicly.